We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restor... Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor. Show more
– Aberrant TRIM7 expression identified as a key driver of immune checkpoint blockade (ICB) acquired resistance; inhibition of TRIM7 with small molecule inhibitors may prevent or reverse acquired...
AUSTIN, TX & DURHAM, NC, April 01, 2024 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional...
AUSTIN, TX and DURHAM, NC, March 04, 2024 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (Nasdaq: STTK), a clinical-stage biotechnology company pioneering the development of bifunctional...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.16 | 1.60481444333 | 9.97 | 10.28 | 9.22 | 277978 | 9.56761688 | CS |
4 | 1.19 | 13.3109619687 | 8.94 | 10.31 | 8.55 | 265830 | 9.49734522 | CS |
12 | 0.91 | 9.86984815618 | 9.22 | 11.11 | 8.06 | 333369 | 9.25256066 | CS |
26 | 8.54 | 537.106918239 | 1.59 | 11.11 | 1.45 | 985378 | 6.38375046 | CS |
52 | 7.2 | 245.733788396 | 2.93 | 11.11 | 1.3301 | 505108 | 6.24966352 | CS |
156 | -19.68 | -66.0181147266 | 29.81 | 38.9 | 1.3301 | 281235 | 8.28235098 | CS |
260 | -8.48 | -45.5668995164 | 18.61 | 60.5162 | 1.3301 | 265930 | 11.07391522 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions